GRYTTE Trademark
Trademark Overview
On Friday, July 29, 2022, a trademark application was filed for GRYTTE with the United States Patent and Trademark Office. The USPTO has given the GRYTTE trademark a serial number of 97525734. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Saturday, September 9, 2023. This trademark is owned by Suzhou Shali Biotechnology Co., Ltd.. The GRYTTE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Biological research; Biological research and analysis; Biomedical research services; Consulting services in the field of pharmacogenetics; Medical research services in the field of cancer; Providing laboratory research services in the field of gene expression, namely, cancer biology; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Scientific research for medical purposes in the area of cancerous diseases; Scientific research for medical purposes in the field of cancerous diseases
General Information
| Serial Number | 97525734 |
| Word Mark | GRYTTE |
| Filing Date | Friday, July 29, 2022 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Saturday, September 9, 2023 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Translation of Words in Mark | The wording Grytte has no meaning in a foreign language. |
| Goods and Services | Biological research; Biological research and analysis; Biomedical research services; Consulting services in the field of pharmacogenetics; Medical research services in the field of cancer; Providing laboratory research services in the field of gene expression, namely, cancer biology; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Scientific research for medical purposes in the area of cancerous diseases; Scientific research for medical purposes in the field of cancerous diseases |
Classification Information
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, August 19, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | Friday, July 1, 2022 |
| First Use In Commerce Date | Friday, July 1, 2022 |
Trademark Owner History
| Party Name | Suzhou Shali Biotechnology Co., Ltd. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Suzhou,Jiangsu 215000
CN |
Trademark Events
| Event Date | Event Description |
| Tuesday, August 2, 2022 | NEW APPLICATION ENTERED |
| Wednesday, May 17, 2023 | ASSIGNED TO EXAMINER |
| Friday, August 19, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Saturday, September 9, 2023 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
| Friday, May 19, 2023 | NON-FINAL ACTION WRITTEN |
| Friday, May 19, 2023 | NON-FINAL ACTION E-MAILED |
| Friday, May 19, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Saturday, September 9, 2023 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Monday, September 11, 2023 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| Tuesday, May 13, 2025 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED |
| Tuesday, May 13, 2025 | WITHDRAWAL OF ATTORNEY GRANTED |
